BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11127101)

  • 41. Automated Papanicolaou smear analysis as a screening tool for female lower genital tract malignancies.
    Ku NN
    Curr Opin Obstet Gynecol; 1999 Feb; 11(1):41-3. PubMed ID: 10047962
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Field test and experimental use of CYBEST model 2 for practical gynecologic mass screening.
    Tanaka N; Ikeda H; Ueno T; Mukawa A; Kamitsuma K
    Anal Quant Cytol; 1979; 1(2):122-6. PubMed ID: 543573
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Terminology of false negative and false positive Pap smears: "They're just worms".
    Naryshkin S; Davey DD
    Diagn Cytopathol; 1996 Feb; 14(1):1-3. PubMed ID: 8834068
    [No Abstract]   [Full Text] [Related]  

  • 44. Routine skin cancer screening in Germany: First data on the impact on health care in dermatology.
    Augustin M; Blome C; Rustenbach SJ; Reusch M; Radtke M
    J Dtsch Dermatol Ges; 2010 Sep; 8(9):674-80. PubMed ID: 20529170
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Episode of care analysis reveals sources of variations in costs.
    de Brantes F; Rastogi A; Soerensen CM
    Am J Manag Care; 2011 Oct; 17(10):e383-92. PubMed ID: 21999718
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The financial implications of coverage of smoking cessation treatment by managed care organizations.
    Warner KE; Mendez D; Smith DG
    Inquiry; 2004; 41(1):57-69. PubMed ID: 15224960
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Costs and benefits of alternative rescreening strategies.
    Schechter CB
    Acta Cytol; 1996; 40(5):1111-4. PubMed ID: 8842186
    [No Abstract]   [Full Text] [Related]  

  • 48. [Planning, execution and results of automated vaginal cytological diagnosis].
    Naujoks H; Sprenger E
    Gynakologe; 1990 Dec; 23(6):322-7. PubMed ID: 2279707
    [No Abstract]   [Full Text] [Related]  

  • 49. A processing strategy for automated Papanicolaou smear screening.
    Lee JS; Bannister WI; Kuan LC; Bartels PH; Nelson AC
    Anal Quant Cytol Histol; 1992 Oct; 14(5):415-25. PubMed ID: 1338567
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Bleeding disorders. The cost of screening].
    Freilev LL
    Sygeplejersken; 1993 Jun; 93(26):17-8. PubMed ID: 8140520
    [No Abstract]   [Full Text] [Related]  

  • 51. Pap smear concerns.
    Moran T
    Tex Med; 1997 Nov; 93(11):44-6. PubMed ID: 9369088
    [No Abstract]   [Full Text] [Related]  

  • 52. Pap smears: diagnostic and screening formats.
    Dunlap P
    Geriatrics; 1995 Aug; 50(8):62. PubMed ID: 7635328
    [No Abstract]   [Full Text] [Related]  

  • 53. Progress report on experimental use of CYBEST model 2 for practical gynecologic mass screening. Alterations of the specimen rejection threshold and specimen preparation.
    Mukawa A; Kamitsuma Y; Jisaki F; Tanaka N; Ikeda H; Ueno T; Tsunekawa S
    Anal Quant Cytol; 1983 Mar; 5(1):31-4. PubMed ID: 6846967
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effectiveness and cost effectiveness of automated and semi-automated cervical screening devices: a systematic review of the literature.
    Broadstock M
    N Z Med J; 2001 Jul; 114(1135):311-3. PubMed ID: 11556445
    [No Abstract]   [Full Text] [Related]  

  • 55. Screening and litigation. Some false negatives arise from negligence.
    Coleman DV
    BMJ; 2000 Sep; 321(7263):761. PubMed ID: 10999919
    [No Abstract]   [Full Text] [Related]  

  • 56. The efficacy and cost of alternative strategies for systematic screening for type 2 diabetes in the U.S. population 45-74 years of age.
    Johnson SL; Tabaei BP; Herman WH
    Diabetes Care; 2005 Feb; 28(2):307-11. PubMed ID: 15677784
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Pap smear, automated rescreening, and negligent nondisclosure.
    Godfrey SE
    Am J Clin Pathol; 1999 Jan; 111(1):14-7. PubMed ID: 9894449
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Automated cervical cytology: meta-analyses of the performance of the AutoPap 300 QC System.
    Abulafia O; Sherer DM
    Obstet Gynecol Surv; 1999 Jul; 54(7):469-76. PubMed ID: 10394585
    [TBL] [Abstract][Full Text] [Related]  

  • 59. How to take a cervical smear.
    Chamberlain G
    Br J Hosp Med; 1980 Feb; 23(2):213-4. PubMed ID: 7370451
    [No Abstract]   [Full Text] [Related]  

  • 60. Assessing the costs and benefits of alternative rescreening strategies.
    Hutchinson ML
    Acta Cytol; 1996; 40(1):4-8. PubMed ID: 8604573
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.